[Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer].
Identifieur interne : 000C50 ( Ncbi/Merge ); précédent : 000C49; suivant : 000C51[Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer].
Auteurs : X W Zheng [République populaire de Chine] ; G. Tao [République populaire de Chine] ; Y W Zhang [République populaire de Chine] ; G N Yang [République populaire de Chine] ; P. Huang [République populaire de Chine]Source :
- Zhonghua nei ke za zhi [ 0578-1426 ] ; 2020.
DOI: 10.3760/cma.j.cn112138-20200219-00097
PubMed: 32114746
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000921
- to stream PubMed, to step Curation: 000921
- to stream PubMed, to step Checkpoint: 000088
Links to Exploration step
pubmed:32114746Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer].</title><author><name sortKey="Zheng, X W" sort="Zheng, X W" uniqKey="Zheng X" first="X W" last="Zheng">X W Zheng</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Cancer Hospital of University of Chinese Academy of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, Cancer Hospital of University of Chinese Academy of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022</wicri:regionArea><placeName><settlement type="city">Hangzhou</settlement><region type="province">Zhejiang</region></placeName></affiliation></author><author><name sortKey="Tao, G" sort="Tao, G" uniqKey="Tao G" first="G" last="Tao">G. Tao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, Zhejiang Medical and Health Centre Hangzhou Hospital , Hangzhou 310022, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Oncology, Zhejiang Medical and Health Centre Hangzhou Hospital , Hangzhou 310022</wicri:regionArea><placeName><settlement type="city">Hangzhou</settlement><region type="province">Zhejiang</region></placeName></affiliation></author><author><name sortKey="Zhang, Y W" sort="Zhang, Y W" uniqKey="Zhang Y" first="Y W" last="Zhang">Y W Zhang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital( People's Hospital of Hangzhou Medical College), Hangzhou 310010, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, Zhejiang Provincial People's Hospital( People's Hospital of Hangzhou Medical College), Hangzhou 310010</wicri:regionArea><placeName><settlement type="city">Hangzhou</settlement><region type="province">Zhejiang</region></placeName></affiliation></author><author><name sortKey="Yang, G N" sort="Yang, G N" uniqKey="Yang G" first="G N" last="Yang">G N Yang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Cancer Hospital of University of Chinese Academy of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, Cancer Hospital of University of Chinese Academy of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022</wicri:regionArea><placeName><settlement type="city">Hangzhou</settlement><region type="province">Zhejiang</region></placeName></affiliation></author><author><name sortKey="Huang, P" sort="Huang, P" uniqKey="Huang P" first="P" last="Huang">P. Huang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital( People's Hospital of Hangzhou Medical College), Hangzhou 310010, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, Zhejiang Provincial People's Hospital( People's Hospital of Hangzhou Medical College), Hangzhou 310010</wicri:regionArea><placeName><settlement type="city">Hangzhou</settlement><region type="province">Zhejiang</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32114746</idno><idno type="pmid">32114746</idno><idno type="doi">10.3760/cma.j.cn112138-20200219-00097</idno><idno type="wicri:Area/PubMed/Corpus">000921</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000921</idno><idno type="wicri:Area/PubMed/Curation">000921</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000921</idno><idno type="wicri:Area/PubMed/Checkpoint">000088</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000088</idno><idno type="wicri:Area/Ncbi/Merge">000C50</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer].</title><author><name sortKey="Zheng, X W" sort="Zheng, X W" uniqKey="Zheng X" first="X W" last="Zheng">X W Zheng</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Cancer Hospital of University of Chinese Academy of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, Cancer Hospital of University of Chinese Academy of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022</wicri:regionArea><placeName><settlement type="city">Hangzhou</settlement><region type="province">Zhejiang</region></placeName></affiliation></author><author><name sortKey="Tao, G" sort="Tao, G" uniqKey="Tao G" first="G" last="Tao">G. Tao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, Zhejiang Medical and Health Centre Hangzhou Hospital , Hangzhou 310022, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Oncology, Zhejiang Medical and Health Centre Hangzhou Hospital , Hangzhou 310022</wicri:regionArea><placeName><settlement type="city">Hangzhou</settlement><region type="province">Zhejiang</region></placeName></affiliation></author><author><name sortKey="Zhang, Y W" sort="Zhang, Y W" uniqKey="Zhang Y" first="Y W" last="Zhang">Y W Zhang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital( People's Hospital of Hangzhou Medical College), Hangzhou 310010, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, Zhejiang Provincial People's Hospital( People's Hospital of Hangzhou Medical College), Hangzhou 310010</wicri:regionArea><placeName><settlement type="city">Hangzhou</settlement><region type="province">Zhejiang</region></placeName></affiliation></author><author><name sortKey="Yang, G N" sort="Yang, G N" uniqKey="Yang G" first="G N" last="Yang">G N Yang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Cancer Hospital of University of Chinese Academy of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, Cancer Hospital of University of Chinese Academy of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022</wicri:regionArea><placeName><settlement type="city">Hangzhou</settlement><region type="province">Zhejiang</region></placeName></affiliation></author><author><name sortKey="Huang, P" sort="Huang, P" uniqKey="Huang P" first="P" last="Huang">P. Huang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital( People's Hospital of Hangzhou Medical College), Hangzhou 310010, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, Zhejiang Provincial People's Hospital( People's Hospital of Hangzhou Medical College), Hangzhou 310010</wicri:regionArea><placeName><settlement type="city">Hangzhou</settlement><region type="province">Zhejiang</region></placeName></affiliation></author></analytic><series><title level="j">Zhonghua nei ke za zhi</title><idno type="ISSN">0578-1426</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32114746</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0578-1426</ISSN><JournalIssue CitedMedium="Print"><Volume>59</Volume><Issue>0</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Zhonghua nei ke za zhi</Title><ISOAbbreviation>Zhonghua Nei Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer].</ArticleTitle><Pagination><MedlinePgn>E004</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112138-20200219-00097</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>X W</ForeName><Initials>XW</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Cancer Hospital of University of Chinese Academy of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Oncology, Zhejiang Medical and Health Centre Hangzhou Hospital , Hangzhou 310022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Y W</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital( People's Hospital of Hangzhou Medical College), Hangzhou 310010, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>G N</ForeName><Initials>GN</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Cancer Hospital of University of Chinese Academy of Sciences, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital( People's Hospital of Hangzhou Medical College), Hangzhou 310010, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Nei Ke Za Zhi</MedlineTA><NlmUniqueID>16210490R</NlmUniqueID><ISSNLinking>0578-1426</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="chi"><AbstractText>新型冠状病毒肺炎治疗药物洛匹那韦/利托那韦（LR）是多种细胞色素P(450)（CYP(450)）酶的抑制剂，又是多种CYP(450)酶底物，此外还是P糖蛋白的抑制剂、葡萄糖醛酸转移酶诱导剂，与很多抗肿瘤药物存在药物相互作用。药品说明书仅列举了少数抗肿瘤药物与LR的相互作用，提供参考信息严重不足。本文系统总结了抗肿瘤药物及常用辅助药物和LR的相互作用及处理建议。.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32114746</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112138-20200219-00097</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country><region><li>Zhejiang</li></region><settlement><li>Hangzhou</li></settlement></list><tree><country name="République populaire de Chine"><region name="Zhejiang"><name sortKey="Zheng, X W" sort="Zheng, X W" uniqKey="Zheng X" first="X W" last="Zheng">X W Zheng</name></region><name sortKey="Huang, P" sort="Huang, P" uniqKey="Huang P" first="P" last="Huang">P. Huang</name><name sortKey="Tao, G" sort="Tao, G" uniqKey="Tao G" first="G" last="Tao">G. Tao</name><name sortKey="Yang, G N" sort="Yang, G N" uniqKey="Yang G" first="G N" last="Yang">G N Yang</name><name sortKey="Zhang, Y W" sort="Zhang, Y W" uniqKey="Zhang Y" first="Y W" last="Zhang">Y W Zhang</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C50 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000C50 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:32114746
|texte= [Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:32114746" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |